BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 10, 2009
View Archived Issues
Nihon Medi-Physics presents compounds useful for the diagnosis of Alzheimer's disease
Read More
Friedrich-Alexander-University claims 5-HT1A receptor agonists as anxiolytics
Read More
AR-67 shows high lactone stability and improved toxicity in phase I trial in refractory solid tumors
Read More
Novel oncolytic adenovirus Ad5/3-Cox2L-D24 shows clinical safety and promising antitumor activity
Read More
Snapshots: promising therapies for central nervous system tumors presented at ASCO
Read More
Pfizer describes prostaglandin EP2 antagonists for the treatment of endometriosis
Read More
Novel antibacterial agents in early development at AstraZeneca
Read More
Novel protein kinase inhibitors discovered by Schering-Plough for cancer treatment
Read More
BN-82451 reduces levodopa-induced dyskinesias in primate Parkinson's disease model
Read More
Positive results seen with fipamezole in proof-of-concept Parkinson's disease study
Read More
AEterna Zentaris reports preliminary results from phase II trial of perifosine in NSCLC
Read More
GSK forms joint venture with Shenzhen for influenza vaccines in China
Read More
EMEA approves DOR BioPharma's design of phase III clinical trial of orBec in GI GVHD
Read More
Peplin initiates phase III trials of PEP-005 in face and scalp actinic keratoses
Read More
InSite to initiate pilot study of ISV-502 in blepharitis to enable revision of phase III protocol
Read More
NOXXON initiates dosing of healthy volunteers in phase I clinical trial of NOX-E36
Read More
Ono initiates clinical testing in Japan of Relistor for opioid-induced constipation
Read More
TD-5108 shows similar effects on bowel function in healthy and constipated subjects
Read More
Novel potent and selective compounds developed by RaQualia for the treatment of GERD
Read More
ZK-EPO is active in metastatic melanoma but not recurrent metastatic breast cancer in phase II trial
Read More
Raptor and Roche sign collaboration agreement for therapeutic delivery across BBB
Read More
Roche selects rHuPH20 as fifth exclusive target under license agreement with Halozyme
Read More
Keryx reports results from phase II study of Zerenex for hyperphosphatemia in ESRD
Read More
Trius reports phase II clinical trial results of torezolid in cSSSI
Read More
ISTA announces phase II results for low-dose bromfenac in dry eye disease
Read More
Pacgen signs share purchase agreement with Xphase
Read More
Pharmasset initiates phase Ib multiple ascending dose trial for PSI-7851 in HCV
Read More
Renovo presents 12-month data for Juvista in varicose vein surgery
Read More
